Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
Bryostatin 1 Alzheimer's Disease (Phase 2) Synaptogenix, Inc. Other Other
Cerebrolysin Alzheimer's Disease (Phase 2) Ebewe Pharmaceutical Other Other
GRF6019 Alzheimer's Disease (Phase 2) Alkahest, Inc., Grifols Biologicals Inc. Inflammation, Other, Unknown Other
Leuprolide Leuprolide acetate ,
Lupron Depot,
Eligard
Alzheimer's Disease (Phase 2) Tolmar Pharmaceuticals, Inc. Other Other Advanced prostate cancer
Liraglutide Victoza™,
Saxenda™
Alzheimer's Disease (Phase 2), Parkinson's Disease (Phase 2) Novo Nordisk A/S Other Other Diabetes, weight loss
Lomecel-B mesenchymal stem cells Alzheimer's Disease (Phase 2) Longeveron Inflammation, Other Other
Nasal Insulin Detemir,
Levemir,
Humulin,
Novolin,
glulisine
Alzheimer's Disease (Phase 2/3), Mild Cognitive Impairment (Phase 2), Parkinson's Disease (Phase 2), Multiple System Atrophy (Phase 2) Amyloid-Related, Other Small Molecule, Other Diabetes
Sargramostim GM-CSF Leukine ,
Leukine®
Alzheimer's Disease (Phase 2), Parkinson's Disease (Phase 1) Genzyme, Partner Therapeutics, Inc., Sanofi Inflammation, Other, Unknown Other Bone Marrow Stimulation
Trappsol® Cyclo™ HP-beta-CD,
HPbetaCD
Alzheimer's Disease (Phase 2) Cyclo Therapeutics, Inc. Cholesterol Other
XPro1595 Pegipanermin, INB03, NeuLiv, XENP1595, DN-TNF, XENP345,
XPro™ ,
LIVNate
Alzheimer's Disease (Phase 2), Mild Cognitive Impairment (Phase 2) INmune Bio Inc. Inflammation Other